For the quarter ending 2025-09-30, CC had $112M increase in cash & cash equivalents over the period. $105M in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net (loss) income | 60 | -384 |
| Depreciation and amortization | 79 | 180 |
| Gain on sales of assets and businesses | 7 | 1 |
| Equity in earnings of affiliates, net | 7 | 16 |
| Amortization of debt issuance costs and issue discounts | 3 | 6 |
| Deferred tax provision (benefit) | -16 | 84 |
| Asset-related charges | 16 | 11 |
| Stock-based compensation expense | 5 | 12 |
| Net periodic pension (income) cost | -1 | - |
| Defined benefit plan contributions | -6 | 8 |
| Other operating charges and credits, net | 5 | 14 |
| Accounts and notes receivable, net | -11 | 174 |
| Inventories and other current operating assets | 34 | 42 |
| Other non-current operating assets | -6 | -64 |
| Accounts payable | 8 | -87 |
| Other current operating liabilities | 9 | 83 |
| Other non-current operating liabilities | 3 | 239 |
| Cash provided by (used for) operating activities | 146 | -19 |
| Purchases of property, plant, and equipment | 41 | 127 |
| Proceeds from sales of assets and businesses | 6 | 1 |
| Foreign exchange contract settlements, net | 1 | 2 |
| Other investing activities | -1 | - |
| Cash used for investing activities | -35 | -128 |
| Proceeds from issuance of debt, net | 0 | 95 |
| Debt repayments | 8 | 111 |
| Payments of debt issuance cost | 0 | 4 |
| Payments on finance leases | 5 | 7 |
| Proceeds from supplier financing program | 17 | 47 |
| Payments to supplier financing program | 17 | 53 |
| Payments related to tax withholdings on vested stock awards | 0 | 1 |
| Payments of dividends to the company's common shareholders | 13 | 50 |
| Other financing activities | 21 | - |
| Cash used for financing activities | -5 | -84 |
| Effect of exchange rate changes on cash, cash equivalents, restricted cash and restricted cash equivalents | 6 | 21 |
| Decrease in cash, cash equivalents, restricted cash and restricted cash equivalents | 112 | -210 |
| Cash and cash equivalents at beginning of period | 763 | - |
| Cash and cash equivalents at end of period | 665 | - |
Chemours Co (CC)
Chemours Co (CC)